One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Fertility Test Market

[ 英語タイトル ] Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023


Product Code : MNMHC00110015
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The fertility test market projected to grow at a CAGR of 7.2% during the forecast period.”
The global fertility test market is projected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing. However, the unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients, and lesser precision of ovulation predictor kits to confirm ovulation are the major factors restricting market growth.

“The female fertility segment is expected to grow at the highest rate during the forecast period.”
On the basis of application, the global fertility test market has been segmented into female fertility testing and male fertility testing. The female fertility testing segment is expected to grow at the higher rate during the forecast period. Factors such as decreasing female fertility rates, availability of a wide range of fertility testing options, and high cost of IVF procedures are driving the high growth of this market segment.

“The home care settings segment accounted for the largest share of fertility test market”
On the basis of end user, the fertility test market is segmented into two major segments, namely, home care settings and hospitals, fertility clinics, and others. The home care settings segment is expected to account for the largest share of the market in 2018. This is mainly attributed to factors such as decline of fertility rates in women and men, increasing need for continuous monitoring of health conditions, and growing preference for home and remote monitoring.

“The APAC market is expected to grow at the highest CAGR during the forecast period”
Geographically, the fertility test market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The APAC market is expected to register the highest growth rate during the forecast period. The fast growth of this segment is mainly due to the growing number of women suffering from lifestyle disorders, increasing healthcare expenditure in these regions, rising funding/investments for the development of fertility and ovulation monitors. Moreover, as markets in developed countries are increasingly becoming saturated, manufacturers and suppliers of fertility test products are shifting their focus towards the Asian market, thereby driving the growth of this market during the forecast period.

Breakdown of supply-side primary interviews:
• By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation - C-level – 26%, Director level – 30%, Others – 44%
• By Region - North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%

The major players in the market included are SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), among others.
Research Coverage

This report studies the fertility test market based on product, mode of purchase, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the fertility test market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Breakdown of primaries 22
2.2 MARKET SIZE ESTIMATION 22
2.2.1 PRODUCT-BASED MARKET ESTIMATION 22
2.2.2 VOLUME-BASED MARKET ESTIMATION 23
2.2.2.1 Bottom-up approach 23
2.2.2.2 Top-down approach 24
2.2.3 PRIMARY RESEARCH VALIDATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 FERTILITY TEST MARKET OVERVIEW 32
4.2 REGIONAL ANALYSIS: FERTILITY TEST MARKET, BY PRODUCT 33
4.3 FERTILITY TESTING MONITORS MARKET, BY PRODUCT 33
4.4 FERTILITY TEST MARKET, BY MODE OF PURCHASE 34
4.5 FERTILITY TEST MARKET, BY APPLICATION 34
4.6 REGIONAL ANALYSIS: FERTILITY TEST MARKET, BY END USER 35
4.7 FERTILITY TEST MARKET, BY COUNTRY 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Increasing first-time pregnancy age 38
5.2.1.2 Declining fertility rates across the globe 38
5.2.1.3 Launch of advanced, easy-to-use fertility monitors with high accuracy 39
5.2.1.4 Increasing awareness about fertility testing 40
5.2.2 RESTRAINTS 41
5.2.2.1 Lesser precision of ovulation prediction kits 41
5.2.2.2 Unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 Emergence of combined kits for dual testing of pregnancy and ovulation 42
5.2.3.2 Emerging nations to offer new growth avenues 42
5.2.3.3 High cost and low accuracy of IVF treatment 43
5.2.4 CHALLENGES 43
5.2.4.1 High cost of fertility testing monitors 43
5.3 INDUSTRY TRENDS 44
5.3.1 RISING ADOPTION OF BASAL BODY TEMPERATURE-BASED OVULATION MONITORS 44
5.3.2 EASY AVAILABILITY OF OVULATION MONITORS ON E-COMMERCE WEBSITES 44
5.4 BURNING ISSUES 44
5.4.1 INCREASING USE OF OVULATION TRACKING MOBILE APPS AND FERTILITY-TRACKING WEBSITES 44
5.4.2 INCREASING USE OF FERTILITY TESTING DEVICES AND APPS AS A CONTRACEPTIVE MEASURE 45
6 FERTILITY TEST MARKET, BY PRODUCT 47
6.1 INTRODUCTION 48
6.2 OVULATION PREDICTOR KITS 49
6.3 FERTILITY MONITORS 50
6.3.1 URINE-BASED MONITORS 51
6.3.2 SALIVA-BASED MONITORS 52
6.3.3 OTHER FERTILITY MONITORS 53
6.4 MALE FERTILITY TESTING PRODUCTS 54
7 FERTILITY TEST MARKET, BY MODE OF PURCHASE 56
7.1 INTRODUCTION 57
7.2 NON-PRESCRIPTION/OTC-BASED 58
7.3 PRESCRIPTION-BASED 59

8 FERTILITY TEST MARKET, BY APPLICATION 61
8.1 INTRODUCTION 62
8.2 FEMALE FERTILITY TESTING 63
8.3 MALE FERTILITY TESTING 64
9 FERTILITY TEST MARKET, BY END USER 66
9.1 INTRODUCTION 67
9.2 HOME CARE SETTINGS 68
9.3 HOSPITALS, FERTILITY CLINICS, & OTHERS 69
10 FERTILITY TESTS MARKET, BY REGION 71
10.1 INTRODUCTION 72
10.2 NORTH AMERICA 73
10.2.1 US 77
10.2.2 CANADA 79
10.3 EUROPE 81
10.3.1 GERMANY 85
10.3.2 FRANCE 87
10.3.3 UK 89
10.3.4 REST OF EUROPE 90
10.4 ASIA PACIFIC 93
10.4.1 CHINA 97
10.4.2 JAPAN 98
10.4.3 INDIA 100
10.4.4 REST OF ASIA PACIFIC 102
10.5 REST OF THE WORLD (ROW) 104
11 COMPETITIVE LANDSCAPE 108
11.1 INTRODUCTION 108
11.2 MARKET SHARE ANALYSIS 108
11.3 COMPETITIVE SCENARIO 109
11.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS 109
11.3.2 ACQUISITION 109
11.3.3 INVESTMENT 109
12 COMPANY PROFILES 110
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 SWISS PRECISION DIAGNOSTICS (SPD) 110
12.2 CHURCH & DWIGHT 112
12.3 PRESTIGE BRANDS HOLDINGS (A PART OF GREGORY PHARMACEUTICAL HOLDINGS) 114
12.4 BIOZHENA 116
12.5 FAIRHAVEN HEALTH 117
12.6 FERTILITY FOCUS 119
12.7 GERATHERM MEDICAL 120
12.8 HILIN LIFE PRODUCTS 122
12.9 TAIDOC 123
12.10 UEBE MEDICAL 125
12.11 ADVACARE PHARMA 126
12.12 AVA 127
12.13 BABYSTART 128
12.14 VALLEY ELECTRONICS 129
12.15 SENSIIA 130

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 131
13.1 INSIGHTS OF INDUSTRY EXPERTS 131
13.2 DISCUSSION GUIDE 132
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 136
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 138
13.5 AVAILABLE CUSTOMIZATIONS 139
13.6 RELATED REPORTS 139
13.7 AUTHOR DETAILS 140

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+